Total: £ 56.28
Published Date: 2025-05-06 | Pages: 102 | Tables: 105 | Pharma & Healthcare
The global market for Pharma & Cosmetics was valued at US$ 1843340 million in the year 2024 and is projected to reach a revised size of US$ 2306310 million by 2031, growing at a CAGR of 3.3% during the forecast period.
Pharma is a substance of the prevention or treatment for human diseases. It can be divided into natural medicine and synthetic medicine according to the source. Pharma is a material which can prevent and treat disease, reduce pain, improve health, or enhance the body"s resistance to disease or to help diagnose diseases.
The major players in global Pharma & Cosmetics market include Johnson & Johnson, Roche, Novartis, etc., and the market concentration rate is low. China and Japan are main markets, they occupy about 40% of the global market. Pharmaceuticals, OTC is the main application, which holds a share about 75%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharma & Cosmetics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma & Cosmetics.
The Pharma & Cosmetics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharma & Cosmetics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharma & Cosmetics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Johnson & Johnson
Roche
Novartis
Pfizer
Sanofi
Eli Lilly
GSK
Bayer
Merck & Co
L' OREAL
Unilever
Procter & Gamble
Estee Lauder
Kao
Shiseido
Beiersdorf
Henkel
Shanghai Jahwa
Segment by Type
Ointments
Creams
Gels
Others
Segment by Application
Pharmaceuticals, OTC
Cosmetics
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharma & Cosmetics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharma & Cosmetics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Pharma & Cosmetics Market Overview
1.1 Product Definition
1.2 Pharma & Cosmetics by Type
1.2.1 Global Pharma & Cosmetics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Ointments
1.2.3 Creams
1.2.4 Gels
1.2.5 Others
1.3 Pharma & Cosmetics by Application
1.3.1 Global Pharma & Cosmetics Market Value by Application (2024 VS 2031)
1.3.2 Pharmaceuticals, OTC
1.3.3 Cosmetics
1.4 Global Pharma & Cosmetics Market Size Estimates and Forecasts
1.4.1 Global Pharma & Cosmetics Revenue 2020-2031
1.4.2 Global Pharma & Cosmetics Sales 2020-2031
1.4.3 Global Pharma & Cosmetics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pharma & Cosmetics Market Competition by Manufacturers
2.1 Global Pharma & Cosmetics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pharma & Cosmetics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pharma & Cosmetics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pharma & Cosmetics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharma & Cosmetics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharma & Cosmetics, Product Type & Application
2.7 Global Key Manufacturers of Pharma & Cosmetics, Date of Enter into This Industry
2.8 Global Pharma & Cosmetics Market Competitive Situation and Trends
2.8.1 Global Pharma & Cosmetics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pharma & Cosmetics Players Market Share by Revenue
2.8.3 Global Pharma & Cosmetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharma & Cosmetics Market Scenario by Region
3.1 Global Pharma & Cosmetics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pharma & Cosmetics Sales by Region: 2020-2031
3.2.1 Global Pharma & Cosmetics Sales by Region: 2020-2025
3.2.2 Global Pharma & Cosmetics Sales by Region: 2026-2031
3.3 Global Pharma & Cosmetics Revenue by Region: 2020-2031
3.3.1 Global Pharma & Cosmetics Revenue by Region: 2020-2025
3.3.2 Global Pharma & Cosmetics Revenue by Region: 2026-2031
3.4 North America Pharma & Cosmetics Market Facts & Figures by Country
3.4.1 North America Pharma & Cosmetics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pharma & Cosmetics Sales by Country (2020-2031)
3.4.3 North America Pharma & Cosmetics Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Pharma & Cosmetics Market Facts & Figures by Country
3.5.1 Europe Pharma & Cosmetics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pharma & Cosmetics Sales by Country (2020-2031)
3.5.3 Europe Pharma & Cosmetics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharma & Cosmetics Market Facts & Figures by Region
3.6.1 Asia Pacific Pharma & Cosmetics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pharma & Cosmetics Sales by Region (2020-2031)
3.6.3 Asia Pacific Pharma & Cosmetics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pharma & Cosmetics Market Facts & Figures by Country
3.7.1 Latin America Pharma & Cosmetics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pharma & Cosmetics Sales by Country (2020-2031)
3.7.3 Latin America Pharma & Cosmetics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharma & Cosmetics Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharma & Cosmetics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pharma & Cosmetics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pharma & Cosmetics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharma & Cosmetics Sales by Type (2020-2031)
4.1.1 Global Pharma & Cosmetics Sales by Type (2020-2025)
4.1.2 Global Pharma & Cosmetics Sales by Type (2026-2031)
4.1.3 Global Pharma & Cosmetics Sales Market Share by Type (2020-2031)
4.2 Global Pharma & Cosmetics Revenue by Type (2020-2031)
4.2.1 Global Pharma & Cosmetics Revenue by Type (2020-2025)
4.2.2 Global Pharma & Cosmetics Revenue by Type (2026-2031)
4.2.3 Global Pharma & Cosmetics Revenue Market Share by Type (2020-2031)
4.3 Global Pharma & Cosmetics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pharma & Cosmetics Sales by Application (2020-2031)
5.1.1 Global Pharma & Cosmetics Sales by Application (2020-2025)
5.1.2 Global Pharma & Cosmetics Sales by Application (2026-2031)
5.1.3 Global Pharma & Cosmetics Sales Market Share by Application (2020-2031)
5.2 Global Pharma & Cosmetics Revenue by Application (2020-2031)
5.2.1 Global Pharma & Cosmetics Revenue by Application (2020-2025)
5.2.2 Global Pharma & Cosmetics Revenue by Application (2026-2031)
5.2.3 Global Pharma & Cosmetics Revenue Market Share by Application (2020-2031)
5.3 Global Pharma & Cosmetics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson & Johnson
6.1.1 Johnson & Johnson Company Information
6.1.2 Johnson & Johnson Description and Business Overview
6.1.3 Johnson & Johnson Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson & Johnson Pharma & Cosmetics Product Portfolio
6.1.5 Johnson & Johnson Recent Developments/Updates
6.2 Roche
6.2.1 Roche Company Information
6.2.2 Roche Description and Business Overview
6.2.3 Roche Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Roche Pharma & Cosmetics Product Portfolio
6.2.5 Roche Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Company Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Novartis Pharma & Cosmetics Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Company Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Pfizer Pharma & Cosmetics Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Pharma & Cosmetics Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Eli Lilly
6.6.1 Eli Lilly Company Information
6.6.2 Eli Lilly Description and Business Overview
6.6.3 Eli Lilly Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Eli Lilly Pharma & Cosmetics Product Portfolio
6.6.5 Eli Lilly Recent Developments/Updates
6.7 GSK
6.7.1 GSK Company Information
6.7.2 GSK Description and Business Overview
6.7.3 GSK Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 GSK Pharma & Cosmetics Product Portfolio
6.7.5 GSK Recent Developments/Updates
6.8 Bayer
6.8.1 Bayer Company Information
6.8.2 Bayer Description and Business Overview
6.8.3 Bayer Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Bayer Pharma & Cosmetics Product Portfolio
6.8.5 Bayer Recent Developments/Updates
6.9 Merck & Co
6.9.1 Merck & Co Company Information
6.9.2 Merck & Co Description and Business Overview
6.9.3 Merck & Co Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Merck & Co Pharma & Cosmetics Product Portfolio
6.9.5 Merck & Co Recent Developments/Updates
6.10 L' OREAL
6.10.1 L' OREAL Company Information
6.10.2 L' OREAL Description and Business Overview
6.10.3 L' OREAL Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 L' OREAL Pharma & Cosmetics Product Portfolio
6.10.5 L' OREAL Recent Developments/Updates
6.11 Unilever
6.11.1 Unilever Company Information
6.11.2 Unilever Description and Business Overview
6.11.3 Unilever Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Unilever Pharma & Cosmetics Product Portfolio
6.11.5 Unilever Recent Developments/Updates
6.12 Procter & Gamble
6.12.1 Procter & Gamble Company Information
6.12.2 Procter & Gamble Description and Business Overview
6.12.3 Procter & Gamble Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Procter & Gamble Pharma & Cosmetics Product Portfolio
6.12.5 Procter & Gamble Recent Developments/Updates
6.13 Estee Lauder
6.13.1 Estee Lauder Company Information
6.13.2 Estee Lauder Description and Business Overview
6.13.3 Estee Lauder Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Estee Lauder Pharma & Cosmetics Product Portfolio
6.13.5 Estee Lauder Recent Developments/Updates
6.14 Kao
6.14.1 Kao Company Information
6.14.2 Kao Description and Business Overview
6.14.3 Kao Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Kao Pharma & Cosmetics Product Portfolio
6.14.5 Kao Recent Developments/Updates
6.15 Shiseido
6.15.1 Shiseido Company Information
6.15.2 Shiseido Description and Business Overview
6.15.3 Shiseido Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Shiseido Pharma & Cosmetics Product Portfolio
6.15.5 Shiseido Recent Developments/Updates
6.16 Beiersdorf
6.16.1 Beiersdorf Company Information
6.16.2 Beiersdorf Description and Business Overview
6.16.3 Beiersdorf Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Beiersdorf Pharma & Cosmetics Product Portfolio
6.16.5 Beiersdorf Recent Developments/Updates
6.17 Henkel
6.17.1 Henkel Company Information
6.17.2 Henkel Description and Business Overview
6.17.3 Henkel Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Henkel Pharma & Cosmetics Product Portfolio
6.17.5 Henkel Recent Developments/Updates
6.18 Shanghai Jahwa
6.18.1 Shanghai Jahwa Company Information
6.18.2 Shanghai Jahwa Description and Business Overview
6.18.3 Shanghai Jahwa Pharma & Cosmetics Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Shanghai Jahwa Pharma & Cosmetics Product Portfolio
6.18.5 Shanghai Jahwa Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharma & Cosmetics Industry Chain Analysis
7.2 Pharma & Cosmetics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharma & Cosmetics Production Mode & Process Analysis
7.4 Pharma & Cosmetics Sales and Marketing
7.4.1 Pharma & Cosmetics Sales Channels
7.4.2 Pharma & Cosmetics Distributors
7.5 Pharma & Cosmetics Customer Analysis
8 Pharma & Cosmetics Market Dynamics
8.1 Pharma & Cosmetics Industry Trends
8.2 Pharma & Cosmetics Market Drivers
8.3 Pharma & Cosmetics Market Challenges
8.4 Pharma & Cosmetics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pharma & Cosmetics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pharma & Cosmetics Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Pharma & Cosmetics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pharma & Cosmetics Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Pharma & Cosmetics Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Pharma & Cosmetics Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Pharma & Cosmetics Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Pharma & Cosmetics Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Pharma & Cosmetics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pharma & Cosmetics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pharma & Cosmetics, Product Type & Application
Table 12. Global Key Manufacturers of Pharma & Cosmetics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharma & Cosmetics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma & Cosmetics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharma & Cosmetics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Pharma & Cosmetics Sales by Region (2020-2025) & (K Units)
Table 18. Global Pharma & Cosmetics Sales Market Share by Region (2020-2025)
Table 19. Global Pharma & Cosmetics Sales by Region (2026-2031) & (K Units)
Table 20. Global Pharma & Cosmetics Sales Market Share by Region (2026-2031)
Table 21. Global Pharma & Cosmetics Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Pharma & Cosmetics Revenue Market Share by Region (2020-2025)
Table 23. Global Pharma & Cosmetics Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Pharma & Cosmetics Revenue Market Share by Region (2026-2031)
Table 25. North America Pharma & Cosmetics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Pharma & Cosmetics Sales by Country (2020-2025) & (K Units)
Table 27. North America Pharma & Cosmetics Sales by Country (2026-2031) & (K Units)
Table 28. North America Pharma & Cosmetics Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Pharma & Cosmetics Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Pharma & Cosmetics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Pharma & Cosmetics Sales by Country (2020-2025) & (K Units)
Table 32. Europe Pharma & Cosmetics Sales by Country (2026-2031) & (K Units)
Table 33. Europe Pharma & Cosmetics Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Pharma & Cosmetics Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Pharma & Cosmetics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Pharma & Cosmetics Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Pharma & Cosmetics Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Pharma & Cosmetics Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Pharma & Cosmetics Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pharma & Cosmetics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Pharma & Cosmetics Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Pharma & Cosmetics Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Pharma & Cosmetics Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pharma & Cosmetics Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Pharma & Cosmetics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Pharma & Cosmetics Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Pharma & Cosmetics Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Pharma & Cosmetics Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Pharma & Cosmetics Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Pharma & Cosmetics Sales (K Units) by Type (2020-2025)
Table 51. Global Pharma & Cosmetics Sales (K Units) by Type (2026-2031)
Table 52. Global Pharma & Cosmetics Sales Market Share by Type (2020-2025)
Table 53. Global Pharma & Cosmetics Sales Market Share by Type (2026-2031)
Table 54. Global Pharma & Cosmetics Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Pharma & Cosmetics Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Pharma & Cosmetics Revenue Market Share by Type (2020-2025)
Table 57. Global Pharma & Cosmetics Revenue Market Share by Type (2026-2031)
Table 58. Global Pharma & Cosmetics Price (USD/Unit) by Type (2020-2025)
Table 59. Global Pharma & Cosmetics Price (USD/Unit) by Type (2026-2031)
Table 60. Global Pharma & Cosmetics Sales (K Units) by Application (2020-2025)
Table 61. Global Pharma & Cosmetics Sales (K Units) by Application (2026-2031)
Table 62. Global Pharma & Cosmetics Sales Market Share by Application (2020-2025)
Table 63. Global Pharma & Cosmetics Sales Market Share by Application (2026-2031)
Table 64. Global Pharma & Cosmetics Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Pharma & Cosmetics Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Pharma & Cosmetics Revenue Market Share by Application (2020-2025)
Table 67. Global Pharma & Cosmetics Revenue Market Share by Application (2026-2031)
Table 68. Global Pharma & Cosmetics Price (USD/Unit) by Application (2020-2025)
Table 69. Global Pharma & Cosmetics Price (USD/Unit) by Application (2026-2031)
Table 70. Johnson & Johnson Company Information
Table 71. Johnson & Johnson Description and Business Overview
Table 72. Johnson & Johnson Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Johnson & Johnson Pharma & Cosmetics Product
Table 74. Johnson & Johnson Recent Developments/Updates
Table 75. Roche Company Information
Table 76. Roche Description and Business Overview
Table 77. Roche Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Roche Pharma & Cosmetics Product
Table 79. Roche Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Novartis Pharma & Cosmetics Product
Table 84. Novartis Recent Developments/Updates
Table 85. Pfizer Company Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Pfizer Pharma & Cosmetics Product
Table 89. Pfizer Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Sanofi Pharma & Cosmetics Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Eli Lilly Company Information
Table 96. Eli Lilly Description and Business Overview
Table 97. Eli Lilly Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Eli Lilly Pharma & Cosmetics Product
Table 99. Eli Lilly Recent Developments/Updates
Table 100. GSK Company Information
Table 101. GSK Description and Business Overview
Table 102. GSK Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. GSK Pharma & Cosmetics Product
Table 104. GSK Recent Developments/Updates
Table 105. Bayer Company Information
Table 106. Bayer Description and Business Overview
Table 107. Bayer Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Bayer Pharma & Cosmetics Product
Table 109. Bayer Recent Developments/Updates
Table 110. Merck & Co Company Information
Table 111. Merck & Co Description and Business Overview
Table 112. Merck & Co Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Merck & Co Pharma & Cosmetics Product
Table 114. Merck & Co Recent Developments/Updates
Table 115. L' OREAL Company Information
Table 116. L' OREAL Description and Business Overview
Table 117. L' OREAL Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. L' OREAL Pharma & Cosmetics Product
Table 119. L' OREAL Recent Developments/Updates
Table 120. Unilever Company Information
Table 121. Unilever Description and Business Overview
Table 122. Unilever Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Unilever Pharma & Cosmetics Product
Table 124. Unilever Recent Developments/Updates
Table 125. Procter & Gamble Company Information
Table 126. Procter & Gamble Description and Business Overview
Table 127. Procter & Gamble Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Procter & Gamble Pharma & Cosmetics Product
Table 129. Procter & Gamble Recent Developments/Updates
Table 130. Estee Lauder Company Information
Table 131. Estee Lauder Description and Business Overview
Table 132. Estee Lauder Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Estee Lauder Pharma & Cosmetics Product
Table 134. Estee Lauder Recent Developments/Updates
Table 135. Kao Company Information
Table 136. Kao Description and Business Overview
Table 137. Kao Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Kao Pharma & Cosmetics Product
Table 139. Kao Recent Developments/Updates
Table 140. Shiseido Company Information
Table 141. Shiseido Description and Business Overview
Table 142. Shiseido Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Shiseido Pharma & Cosmetics Product
Table 144. Shiseido Recent Developments/Updates
Table 145. Beiersdorf Company Information
Table 146. Beiersdorf Description and Business Overview
Table 147. Beiersdorf Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Beiersdorf Pharma & Cosmetics Product
Table 149. Beiersdorf Recent Developments/Updates
Table 150. Henkel Company Information
Table 151. Henkel Description and Business Overview
Table 152. Henkel Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Henkel Pharma & Cosmetics Product
Table 154. Henkel Recent Developments/Updates
Table 155. Shanghai Jahwa Company Information
Table 156. Shanghai Jahwa Description and Business Overview
Table 157. Shanghai Jahwa Pharma & Cosmetics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. Shanghai Jahwa Pharma & Cosmetics Product
Table 159. Shanghai Jahwa Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Pharma & Cosmetics Distributors List
Table 163. Pharma & Cosmetics Customers List
Table 164. Pharma & Cosmetics Market Trends
Table 165. Pharma & Cosmetics Market Drivers
Table 166. Pharma & Cosmetics Market Challenges
Table 167. Pharma & Cosmetics Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharma & Cosmetics
Figure 2. Global Pharma & Cosmetics Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharma & Cosmetics Market Share by Type: 2024 & 2031
Figure 4. Ointments Product Picture
Figure 5. Creams Product Picture
Figure 6. Gels Product Picture
Figure 7. Others Product Picture
Figure 8. Global Pharma & Cosmetics Market Value by Application (2020-2031) & (US$ Million)
Figure 9. Global Pharma & Cosmetics Market Share by Application: 2024 & 2031
Figure 10. Pharmaceuticals, OTC
Figure 11. Cosmetics
Figure 12. Global Pharma & Cosmetics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Pharma & Cosmetics Market Size (2020-2031) & (US$ Million)
Figure 14. Global Pharma & Cosmetics Sales (2020-2031) & (K Units)
Figure 15. Global Pharma & Cosmetics Average Price (USD/Unit) & (2020-2031)
Figure 16. Pharma & Cosmetics Report Years Considered
Figure 17. Pharma & Cosmetics Sales Share by Manufacturers in 2024
Figure 18. Global Pharma & Cosmetics Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Pharma & Cosmetics Players: Market Share by Revenue in Pharma & Cosmetics in 2024
Figure 20. Pharma & Cosmetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Pharma & Cosmetics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Pharma & Cosmetics Sales Market Share by Country (2020-2031)
Figure 23. North America Pharma & Cosmetics Revenue Market Share by Country (2020-2031)
Figure 24. U.S. Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Pharma & Cosmetics Sales Market Share by Country (2020-2031)
Figure 27. Europe Pharma & Cosmetics Revenue Market Share by Country (2020-2031)
Figure 28. Germany Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Pharma & Cosmetics Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Pharma & Cosmetics Revenue Market Share by Region (2020-2031)
Figure 35. China Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Indonesia Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Thailand Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Malaysia Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Latin America Pharma & Cosmetics Sales Market Share by Country (2020-2031)
Figure 45. Latin America Pharma & Cosmetics Revenue Market Share by Country (2020-2031)
Figure 46. Mexico Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Brazil Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Argentina Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Middle East and Africa Pharma & Cosmetics Sales Market Share by Country (2020-2031)
Figure 50. Middle East and Africa Pharma & Cosmetics Revenue Market Share by Country (2020-2031)
Figure 51. Turkey Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. UAE Pharma & Cosmetics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Global Sales Market Share of Pharma & Cosmetics by Type (2020-2031)
Figure 55. Global Revenue Market Share of Pharma & Cosmetics by Type (2020-2031)
Figure 56. Global Pharma & Cosmetics Price (USD/Unit) by Type (2020-2031)
Figure 57. Global Sales Market Share of Pharma & Cosmetics by Application (2020-2031)
Figure 58. Global Revenue Market Share of Pharma & Cosmetics by Application (2020-2031)
Figure 59. Global Pharma & Cosmetics Price (USD/Unit) by Application (2020-2031)
Figure 60. Pharma & Cosmetics Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed